Episodios

  • HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib With Beth Sandy, MSN, CRNP, FAPO

    HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib With Beth Sandy, MSN, CRNP, FAPO
    Apr 3 2026
    Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! https://i3health.com/course-information/nsclc-advances The FDA’s recent expanded approval of zongertinib marks a significant milestone in the treatment of non-small cell lung cancer (NSCLC). As the first oral human epidermal growth factor receptor 2 (HER2) inhibitor to move into the frontline setting, this therapy offers a new standard of care for patients with metastatic or unresectable non-squamous NSCLC harboring HER2 mutations. Following the approval, Beth Sandy, Thoracic Oncology Nurse Practitioner at the University of Pennsylvania, sat down to explore its clinical implications, including efficacy data, side effect management, and the potential of having a once-daily oral pill for improving patient experiences.
    Más Menos
    6 m
  • The Future of Hemophilia: New Data, New Guidance, New Outcomes with Robert F. Sidonio, Jr., MD, MSc

    The Future of Hemophilia: New Data, New Guidance, New Outcomes with Robert F. Sidonio, Jr., MD, MSc
    Mar 25 2026
    Hemophilia care is evolving faster than ever. Dr. Robert Sidonio, Jr., a leading expert from Children’s Healthcare of Atlanta, joins us to discuss the latest breakthroughs in research and clinical trials. From navigating new treatment options to the importance of personalized patient selection, Dr. Sidonio shares the "real-world" perspective clinicians need to stay ahead. Listen now to discover what the future holds for hemophilia management! Click here to complete the activity, Raising the Bar for Hemophilia Management, and claim your CME credit: https://bit.ly/3Ini6vj
    Más Menos
    10 m
  • Advancing Care in Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 2

    Advancing Care in Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 2
    Mar 13 2026
    Treatment for systemic mastocytosis (SM) has evolved fast—are your management strategies keeping up? Join Dr. Castells as she dives into the latest advances in SM therapy, including how and when to leverage tyrosine kinase inhibitors, and how to collaborate across specialties to tailor care that truly meets each patient’s needs. Packed with practical pearls and forward‑looking insights, this episode will help you elevate symptom control, safety, and quality of life for your patients. Listen now before this accredited activity expires on April 15! Click here to claim your CME/NCPD/AAPA credit: https://bit.ly/4cxzgAK
    Más Menos
    28 m
  • Unlocking Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 1

    Unlocking Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 1
    Mar 13 2026
    Systemic mastocytosis (SM) can hide in plain sight—are you catching it when it counts? In this case‑driven conversation, Dr. Mariana Castells breaks down the real-world diagnostic journey of SM, highlighting the subtle clues, surprising presentations, and essential criteria every oncology professional should have on their radar. Listen now and feel better equipped to recognize SM early, avoid common diagnostic pitfalls, and confidently guide patients toward the answers they need. Don’t miss your chance to earn credit—this episode expires April 15. Click here to claim your CME/NCPD/AAPA credit: https://bit.ly/42vUKJJ Click here to continue with this series and listen to Module 2:
    Más Menos
    30 m
  • Rethinking Schizophrenia: Multidimensional Symptoms and Modern Management

    Rethinking Schizophrenia: Multidimensional Symptoms and Modern Management
    Mar 13 2026
    Schizophrenia is far more than hallucinations and delusions. In this Faculty Follow-Up, Christoph U. Correll, MD—Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at Hofstra/Northwell and Chair of Child and Adolescent Psychiatry at Charité University in Berlin—joins us to unpack the full multidimensional nature of schizophrenia. Dr. Correll explores how our understanding of positive, negative, and cognitive symptoms continues to evolve, why these domains matter for real-world functioning, and how to better identify and treat often-overlooked symptom clusters. He also highlights practical strategies for multidisciplinary collaboration, engaging patients and families in shared decision making, and integrating emerging evidence into everyday practice to optimize outcomes. To dive deeper into this topic and earn CME/NCPD/AAPA/CPE credit, view Dr. Correll’s full activity and here: https://bit.ly/3KSTtHK
    Más Menos
    10 m
  • Closing the Gaps in NET Diagnosis and Treatment: A Conversation With Aman Chauhan, MD

    Closing the Gaps in NET Diagnosis and Treatment: A Conversation With Aman Chauhan, MD
    Mar 12 2026
    Neuroendocrine tumor (NET) care is changing fast—and the pace of innovation is only accelerating. In this episode, Aman Chauhan, MD, Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF), breaks down the latest advances that are reshaping how clinicians diagnose and treat NETs. Dr. Chauhan, who recently chaired i3 Health’s CME activity Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care, returns to highlight what’s new and what matters most for practice. From evolving epidemiologic insights to emerging targeted therapies and next‑generation immunotherapies, he explains how these developments are expanding options for patients and refining real‑world decision making. Whether you’re a clinician treating NETs, a trainee looking to stay current, or a listener interested in where cancer care is headed next, this conversation offers a concise, high‑yield tour of the NET landscape—and where it’s going next. Click the link to view the full activity and claim your free CME credit: bit.ly/41Qo65Y Click here to download/view the infographic: bit.ly/4bbSUmL
    Más Menos
    18 m
  • Breaking Barriers in Biliary Tract Cancer: Innovations, Trials, and Advocacy

    Breaking Barriers in Biliary Tract Cancer: Innovations, Trials, and Advocacy
    Mar 4 2026
    Biliary tract cancers, including cholangiocarcinoma, are among the most complex and aggressive malignancies in oncology. In this episode, we are joined by Melinda Bachini, Chief Patient Officer at the Cholangiocarcinoma Foundation and a remarkable 16-year survivor of stage IV intrahepatic cholangiocarcinoma. Following her participation in i3 Health’s Multidisciplinary Task Force, Melinda shares her unique perspective on the challenges of diagnosis, the critical role of clinical trials, and how the advocacy community is driving innovation forward. Whether you are a clinician looking for multidisciplinary insights or a patient seeking hope and resources, this conversation highlights the vital intersection of medical advancement and the patient voice. Explore more from the Task Force: Earn Credit: Listen to the CME/NCPD/AAPA-accredited podcast here: https://bit.ly/40unnqt Watch the Discussion: View the full Task Force recording on YouTube: https://www.youtube.com/live/ZuJpHcqi7dY Read the Research: Access the official Position Statement in Hepatology Communications: https://bit.ly/4b3JpFb
    Más Menos
    40 m
  • Ulcerative Colitis Advances: Latest Research and Clinical Trials with Benjamin Cohen, MD

    Ulcerative Colitis Advances: Latest Research and Clinical Trials with Benjamin Cohen, MD
    Mar 4 2026
    The management of ulcerative colitis (UC) has moved far beyond simple symptom control, evolving into a sophisticated era of precision medicine fueled by an ever-expanding therapeutic armamentarium. Following his popular CME/AAPA-accredited Virtual UC Escape Room, Benjamin Cohen, MD—Co-Section Head and Clinical Director of IBD at the Cleveland Clinic—dives back into the shifting paradigms of modern care. Dr. Cohen breaks down the latest updates in disease management and identifies the critical priorities clinicians must master to optimize outcomes in today’s fast-paced practice environment. Ready to test your clinical skills? Visit i3health.com/uc-escape to challenge yourself in the Virtual Escape Room!
    Más Menos
    5 m